Burzynski Research Institute, Inc.
|
-0.01 USD
|
58433.333%
|
Arch Therapeutics, Inc.
|
-2.27 USD
|
362.115%
|
Evofem Biosciences, Inc.
|
10.35 USD
|
42.512%
|
Nascent Biotech, Inc.
|
-0.01 USD
|
44502.985%
|
Rebus Holdings, Inc.
|
-0.03 USD
|
18635.826%
|
Qrons Inc.
|
-0.06 USD
|
10305.832%
|
Adynxx, Inc.
|
- USD
|
-Infinity%
|
Neon Bloom, Inc.
|
-0.00 USD
|
396766.667%
|
Northwest Biotherapeutics, Inc.
|
-0.06 USD
|
10447.826%
|
ProtoKinetix, Incorporated
|
-0.01 USD
|
59600.0%
|
Skye Bioscience, Inc.
|
-5.37 USD
|
210.801%
|
Eiger BioPharmaceuticals, Inc.
|
-50.78 USD
|
111.717%
|
Nanobac Pharmaceuticals, Incorporated
|
- USD
|
-Infinity%
|
Institute of Biomedical Research Corp.
|
-0.05 USD
|
11653.398%
|
SQZ Biotechnologies Company
|
-2.76 USD
|
315.58%
|
Intellipharmaceutics International Inc.
|
-0.09 USD
|
6907.78%
|
Propanc Biopharma, Inc.
|
-0.02 USD
|
25205.485%
|
Mesoblast Limited
|
-0.09 USD
|
6777.89%
|
Marizyme, Inc.
|
-1.44 USD
|
513.194%
|
Genus plc
|
0.12 USD
|
-4858.333%
|
VioQuest Pharmaceuticals, Inc.
|
-2.33 USD
|
355.365%
|
Pharming Group N.V.
|
-0.02 USD
|
37056.522%
|
Therapeutic Solutions International, Inc.
|
-0.00 USD
|
850100.0%
|
CNBX Pharmaceuticals Inc.
|
-0.42 USD
|
1516.667%
|
Nymox Pharmaceutical Corporation
|
-0.10 USD
|
6265.803%
|
ContraFect Corporation
|
-124.97 USD
|
104.761%
|
PsyBio Therapeutics Corp.
|
-0.04 USD
|
14266.667%
|
Sienna Biopharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
RegeneRx Biopharmaceuticals, Inc.
|
-0.01 USD
|
49683.333%
|
IMV Inc.
|
-4.37 USD
|
236.156%
|
AXIM Biotechnologies, Inc.
|
-0.04 USD
|
16907.91%
|
MultiCell Technologies, Inc.
|
-0.00 USD
|
5950100.0%
|
ONE Bio Corp.
|
1.43 USD
|
-316.084%
|
Accustem Sciences Inc.
|
-0.34 USD
|
1850.0%
|
RVL Pharmaceuticals plc
|
-0.58 USD
|
1125.862%
|
Arno Therapeutics, Inc.
|
- USD
|
-Infinity%
|
EV Biologics, Inc.
|
-0.12 USD
|
5058.333%
|
Q BioMed Inc.
|
-0.08 USD
|
7718.438%
|
Emmaus Life Sciences, Inc.
|
-0.07 USD
|
8563.727%
|
Mosaic ImmunoEngineering Inc.
|
-0.33 USD
|
1903.03%
|
Biomind Labs Inc.
|
-0.02 USD
|
36828.395%
|
American Oriental Bioengineering, Inc.
|
-781.24 USD
|
100.762%
|
Provectus Biopharmaceuticals, Inc.
|
-0.01 USD
|
80505.405%
|
TetraLogic Pharmaceuticals Corporation
|
- USD
|
-Infinity%
|
Oncotelic Therapeutics, Inc.
|
-0.02 USD
|
29999.497%
|
GlobeStar Therapeutics Corporation
|
-0.00 USD
|
248016.667%
|
THC Farmaceuticals, Inc.
|
-0.00 USD
|
743850.0%
|
Acro Biomedical Co., Ltd.
|
-0.26 USD
|
2388.462%
|
Curative Biotechnology, Inc.
|
-0.01 USD
|
67713.636%
|
GB Sciences, Inc.
|
-0.00 USD
|
145221.951%
|
Alpha Cognition Inc.
|
-0.15 USD
|
4066.667%
|
HST Global, Inc.
|
-0.03 USD
|
21426.165%
|
CSL Limited
|
2.73 USD
|
-117.949%
|
Wesana Health Holdings Inc.
|
-0.05 USD
|
11976.248%
|
Halberd Corporation
|
-0.00 USD
|
5950100.0%
|
Enzolytics Inc.
|
-0.00 USD
|
850100.0%
|
Agentix Corp.
|
-0.04 USD
|
17100.0%
|
Resverlogix Corp.
|
-0.01 USD
|
42001.408%
|
Nuo Therapeutics, Inc.
|
-0.08 USD
|
7991.247%
|
MetaStat, Inc.
|
- USD
|
-Infinity%
|
argenx SE
|
-5.16 USD
|
215.31%
|
Enzon Pharmaceuticals, Inc.
|
0.00 USD
|
-457592.308%
|
Endonovo Therapeutics, Inc.
|
0.03 USD
|
-23605.179%
|
RespireRx Pharmaceuticals Inc.
|
-0.04 USD
|
16766.667%
|
GeneThera, Inc.
|
- USD
|
-Infinity%
|
Inhibitor Therapeutics, Inc.
|
-0.02 USD
|
29850.0%
|
AVAX Technologies, Inc.
|
-0.05 USD
|
11138.961%
|
Zenith Capital Corp.
|
-0.07 USD
|
8612.16%
|
Genscript Biotech Corporation
|
-0.05 USD
|
13205.727%
|
Ember Therapeutics, Inc.
|
-0.01 USD
|
94544.444%
|
Anthera Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
Sigyn Therapeutics, Inc.
|
-3.77 USD
|
257.825%
|
WPD Pharmaceuticals Inc.
|
-0.00 USD
|
1190100.0%
|
Cotinga Pharmaceuticals Inc.
|
-0.09 USD
|
6616.977%
|
Kadimastem Ltd
|
-0.78 USD
|
862.821%
|
Helix BioMedix, Inc.
|
-4.70 USD
|
226.596%
|
VitaSpring Biomedical Co. Ltd.
|
- USD
|
-Infinity%
|
Capstone Therapeutics Corp.
|
-36.39 USD
|
116.351%
|
BioStem Technologies, Inc.
|
-0.62 USD
|
1059.677%
|
Oncology Pharma Inc.
|
- USD
|
-Infinity%
|
Reve Technologies, Inc.
|
-0.01 USD
|
50100.0%
|
LadRx Corporation
|
0.68 USD
|
-775.0%
|
Cell Source, Inc.
|
-0.17 USD
|
3600.0%
|
Regen BioPharma, Inc.
|
0.29 USD
|
-1951.724%
|
Regen BioPharma, Inc.
|
0.26 USD
|
-2188.462%
|
NovAccess Global Inc.
|
-0.23 USD
|
2686.957%
|
Affymax, Inc.
|
-0.39 USD
|
1625.641%
|
Itoco Inc.
|
-0.01 USD
|
78389.474%
|
Rasna Therapeutics, Inc.
|
-0.01 USD
|
59600.0%
|
Pathfinder Cell Therapy, Inc.
|
-0.00 USD
|
238100.0%
|
Mobile Lads Corp.
|
-0.01 USD
|
106350.0%
|
CytoDyn Inc.
|
-0.05 USD
|
11347.637%
|
Claritas Pharmaceuticals, Inc.
|
- USD
|
-Infinity%
|
NDT Pharmaceuticals Inc.
|
-0.00 USD
|
1190100.0%
|
NanoSphere Health Sciences Inc.
|
-0.02 USD
|
26901.802%
|
Alseres Pharmaceuticals, Inc.
|
-153.67 USD
|
103.872%
|
SYBLEU INC
|
-0.02 USD
|
34100.0%
|
Advanced Proteome Therapeutics Corporation
|
- USD
|
-Infinity%
|
ImmunoCellular Therapeutics, Ltd.
|
-0.01 USD
|
42001.408%
|
International Stem Cell Corporation
|
-0.02 USD
|
36380.488%
|
Bioxytran, Inc.
|
-0.03 USD
|
18752.038%
|
GlobeImmune, Inc.
|
- USD
|
-Infinity%
|
Predictive Technology Group, Inc.
|
- USD
|
-Infinity%
|
ProText Mobility, Inc.
|
- USD
|
-Infinity%
|
Cardax, Inc.
|
- USD
|
-Infinity%
|
VG Life Sciences Inc.
|
-0.00 USD
|
5950100.0%
|
Kaleido Biosciences, Inc.
|
- USD
|
-Infinity%
|
Advaxis, Inc.
|
-7.99 USD
|
174.468%
|
Adhera Therapeutics, Inc.
|
-1.18 USD
|
604.237%
|
RenovaCare, Inc.
|
- USD
|
-Infinity%
|
Regnum Corp.
|
-0.03 USD
|
17600.0%
|
Innovation Pharmaceuticals Inc.
|
-0.01 USD
|
94544.444%
|
Neutra Corp.
|
-0.00 USD
|
5950100.0%
|
Windtree Therapeutics, Inc.
|
-94.23 USD
|
106.314%
|
PureTech Health plc
|
-2.38 USD
|
350.0%
|
Coeptis Therapeutics, Inc.
|
-0.83 USD
|
816.867%
|
IXICO plc
|
-0.02 USD
|
24485.246%
|
IntelGenx Technologies Corp.
|
-0.06 USD
|
10575.352%
|
Gelesis Holdings, Inc.
|
-1.35 USD
|
540.741%
|
CSL Limited
|
5.47 USD
|
-8.775%
|
Cellectis S.A.
|
-1.77 USD
|
436.158%
|